Product Information

GENTAMICIN 0.3% EYE DROP is a generic product labeled by Bausch & Lomb Incorporated, priced at $0.9647 per ML under NDC 24208058060. Its NADAC has been published 678 times since Nov 28, 2013.

FDA first approved this application on May 11, 1994. Its Orange Book therapeutic-equivalence code is AT.

GENTAMICIN 0.3% EYE DROP

Gentamicin Sulfate
$0.9647per ML

Strength

3 mg/mL

NDC

24208058060

Classification

Generic

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Effective Date

11/18/2026

Active Ingredients

GENTAMICIN SULFATE

Approval Type

Generic (ANDA)

FDA Application

ANDA064048

FDA Approved

5/11/1994

TE Code

AT

On Market Since

5/11/1994

Pharmacological Classes

Price Statistics

The NADAC for GENTAMICIN 0.3% EYE DROP has been published 678 times since Nov 28, 2013, and over the history we have for it it has risen 20.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.9647 per ML
All-time high$3.5187 (Nov 11, 2015)
All-time low$0.5222 (Nov 20, 2024)
52-week high$0.9647
52-week low$0.7038
Median price$0.7867
Average price$0.9699
Largest weekly change+343.5% (Oct 21, 2015)
Weeks tracked678
Tracking sinceNov 28, 2013

Price History

1W

+6.3%

1M

+6.3%

3M

+29.5%

6M

+33.4%

1Y

+37.1%

3Y

+16.8%

5Y

+65.2%

All

+20.8%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Gentamicin Sulfate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of GENTAMICIN 0.3% EYE DROP?

The current National Average Drug Acquisition Cost (NADAC) for GENTAMICIN 0.3% EYE DROP, manufactured by Bausch & Lomb Incorporated, is $0.9647 per ML (NDC 24208058060), effective Nov 18, 2026.

How has the price of GENTAMICIN 0.3% EYE DROP changed over time?

Over the history we have for it, the NADAC for GENTAMICIN 0.3% EYE DROP has risen 20.8%. It has been tracked across 678 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for GENTAMICIN 0.3% EYE DROP?

Since Nov 28, 2013, the NADAC for GENTAMICIN 0.3% EYE DROP has ranged from a low of $0.5222 (Nov 20, 2024) to a high of $3.5187 (Nov 11, 2015), with a median of $0.7867 per ML.

Are there cheaper alternatives to GENTAMICIN 0.3% EYE DROP?

No other NADAC-published product currently shares the active ingredient and strength of GENTAMICIN 0.3% EYE DROP in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures GENTAMICIN 0.3% EYE DROP?

GENTAMICIN 0.3% EYE DROP (NDC 24208058060) is labeled by Bausch & Lomb Incorporated, and CMS classifies it as a generic product.